Literature DB >> 24479264

Air travel with known pneumocephalus following outpatient sinus surgery.

Thomas J Willson1, Conor Grady2, Ernest Braxton3, Erik Weitzel3.   

Abstract

BACKGROUND: Intracranial air is a common finding after many neurosurgical procedures and trauma to the head. In patients requiring transport via air to reach a destination there is risk of expansion of the intracranial air and development of neurological complications. Though relatively uncommon after functional endoscopic sinus surgery (FESS), pneumocephalus may be encountered. CASE REPORT: We describe one of our patients in whom intracranial air was introduced during FESS. Following the procedure she required commercial air transportation from our center to her home. A 45-min commercial flight to the destination was safely completed without the patient experiencing any neurological sequellae. DISCUSSION: This case highlights the controversy surrounding air travel with pneumocephalus and provides an example of safe commercial air travel after diagnosis of post-FESS pneumocephalus.

Entities:  

Mesh:

Year:  2014        PMID: 24479264     DOI: 10.3357/asem.3795.2014

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  3 in total

1.  Risk for intracranial pressure increase related to enclosed air in post-craniotomy patients during air ambulance transport: a retrospective cohort study with simulation.

Authors:  Helge Brändström; Anna Sundelin; Daniela Hoseason; Nina Sundström; Richard Birgander; Göran Johansson; Ola Winsö; Lars-Owe Koskinen; Michael Haney
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-05-12       Impact factor: 2.953

Review 2.  Air travel with pneumocephalus: a systematic review.

Authors:  Oliver Bichsel; Annalisa Hauck; Markus Oertel
Journal:  Acta Neurochir (Wien)       Date:  2022-07-06       Impact factor: 2.816

3.  Pneumocephalus and air travel: an experimental investigation on the effects of aircraft cabin pressure on intracranial pressure.

Authors:  Ee Lim; Boon Leong Lan; Ean Hin Ooi; Hu Liang Low
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.